Quick Scan
Our retinal imaging system captures high-quality images in seconds, non-invasive and comfortable.
OptHealth uses advanced AI-based retinal imaging technology to assist healthcare professionals in assessing eye and systemic health indicators. CE-marked and NMPA-approved algorithms are in active use internationally. Preliminary research suggests retinal imaging may reveal insights into broader health conditions.
How It Works
Our retinal imaging system captures high-quality images in seconds, non-invasive and comfortable.
Our CE-marked and NMPA-approved AI engine analyzes retinal images to support clinicians in assessing eye health, with ongoing research exploring correlations with systemic health. Preliminary research shows >90% agreement with expert reviewers.
Receive a clear report designed to help healthcare providers guide next steps in patient care. Early assessment can support earlier clinical follow-up.
Tech-Driven. Clinically Validated. Patient-Centric.
AI algorithms trained to identify retinal features associated with multiple eye conditions, with research exploring possible associations with systemic health. CE- and NMPA-approved models are currently in clinical use in select regions.
CE-marked and NMPA-approved medical AI technology in active use across partner clinics. Pending regulatory submission for North American markets.
CE- and NMPA-approved algorithms deployed across 1,500+ clinics serving over 3 million patients worldwide.
Non-invasive retinal imaging designed for rapid analysis. Preliminary research shows potential for results in under a minute.
Tailored solutions for various healthcare needs and settings.

Supports clinicians caring for patients who may be at higher risk for eye disease, including individuals with diabetes or high blood pressure.

Plug-and-play AI-assisted retinal imaging for optical and wellness settings. Designed to provide summary reports for professional review and discussion.

Empowers clinical specialists with an affordable, fast AI-assisted screening tool. CE- and NMPA-approved models have demonstrated early detection potential in research deployments.
Over 1.5 million retinal images analyzed across global research and clinical partners. CE- and NMPA-approved models have shown >90% agreement with expert clinicians in preliminary studies.
Discover how AI-enabled retinal imaging research is advancing comprehensive health assessment worldwide.